Danish pharmaceutical giant Novo Nordisk was hit with a class action lawsuit in New York federal court on Friday for allegedly misusing its patents to maintain a monopoly on its diabetes drug Victoza.

Bought as a raw shell and built out over the next two years, the half-floor aerie is now available for almost triple what Malibu broker Chris Cortazzo originally paid. The former Washington Capitals ...